Lonza has launched the next generation of its Nucleofector® Platform.

AMSBIO has announced a new range of AAV reference materials of full capsids and empty capsids of 6 different serotypes.

AMSBIO has launched two new biotinylated formats of the 10E4 Heparan Sulfate antibody (high and low biotin) along with a starter pack to allow scientists to test both formats at a reduced cost.

OCF has partnered with RONIN to provide its customers with an easy-to-use application to support and ease the adoption of HPC cloud services in research institutions.

Pharma and biotech laboratories performing high-throughput screening, high-content screening and molecular cell biology can now benefit from a series of new automated incubators and storage solutions that offer a large capacity, fast access and wide temperature range, while helping eliminate contamination issues in high-throughput environments.

Dotmatics has announced that the US Defense Advanced Research Projects Agency (DARPA) has named Charles Fracchia, Founder of Dotmatics BioBright, to its Information Science and Technology (ISAT) Study Group for a three-year term beginning this summer.

Genomic sequencing service provider Macrogen Europe has achieved a significant upgrade to its next-generation sequencing capacity.

Owlstone Medical has announced agreements with Functional Gut Clinic and Functional Gut Diagnostics. The partnership aims to strengthen the provision of efficient and high-quality at-home breath testing through a UK Lab Services Agreement and accelerate the development of future breath tests in digestive health through a Collaboration Agreement.

Memo Therapeutics AG has announced that MTX-COVAB, its human-derived antibody against SARS-CoV-2, the virus that causes COVID-19, has shown efficacy against both the original virus as well as the UK variant (B.1.1.7).

Sphere Fluidics has announced it has enhanced the capability and performance of its Cyto-Mine® System. The simplified design offers improved functionality to help streamline workflows, reduce costs, increase throughput, and enable high-value clones to be captured in a single run.